Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Chinese mobile games developer Playtika completed its initial public offering, the largest of 2021 so far, raising $1.88 billion after selling 69.5 million shares at $27 each, well above the $22 to $24 price range.
Our top pick for
Beginners
Our top pick for
Experienced Investors
Our top pick for
Large Accounts
| Latest market close | $28.56 |
|---|---|
| 52-week range | $20.88 - $36.06 |
| 50-day moving average | $27.13 |
| 200-day moving average | $25.68 |
| Wall St. target price | $39.11 |
| PE ratio | 35.4545 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.80 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $28.56 from 2021-10-20
| 1 week (2021-10-14) | 0.95% |
|---|---|
| 1 month (2021-09-21) | 9.26% |
| 3 months (2021-07-21) | 21.07% |
| 6 months (2021-04-21) | 4.14% |
| 1 year (2020-10-17) | N/A |
|---|---|
| 2 years (2019-10-17) | N/A |
| 3 years (2018-10-17) | N/A |
| 5 years (2016-10-17) | N/A |
Valuing Playtika Holding stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Playtika Holding's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Playtika Holding's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Playtika Holding shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Playtika Holding's P/E ratio is best considered in relation to those of others within the electronic gaming & multimedia industry or those of similar companies.
Playtika Holding's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $756.1 million.
The EBITDA is a measure of a Playtika Holding's overall financial performance and is widely used to measure a its profitability.
To put Playtika Holding's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $2.5 billion |
|---|---|
| Operating margin TTM | 25.6% |
| Gross profit TTM | $1.7 billion |
| Return on assets TTM | 19.57% |
| Return on equity TTM | 0% |
| Profit margin | 12.94% |
| Book value | N/A |
| Market capitalisation | $11.7 billion |
TTM: trailing 12 months
There are currently 14.3 million Playtika Holding shares held short by investors – that's known as Playtika Holding's "short interest". This figure is 6.9% up from 13.4 million last month.
There are a few different ways that this level of interest in shorting Playtika Holding shares can be evaluated.
Playtika Holding's "short interest ratio" (SIR) is the quantity of Playtika Holding shares currently shorted divided by the average quantity of Playtika Holding shares traded daily (recently around 1.1 million). Playtika Holding's SIR currently stands at 12.64. In other words for every 100,000 Playtika Holding shares traded daily on the market, roughly 12640 shares are currently held short.
To gain some more context, you can compare Playtika Holding's short interest ratio against those of similar companies.
However Playtika Holding's short interest can also be evaluated against the total number of Playtika Holding shares, or, against the total number of tradable Playtika Holding shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Playtika Holding's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Playtika Holding shares in existence, roughly 30 shares are currently held short) or 0.1686% of the tradable shares (for every 100,000 tradable Playtika Holding shares, roughly 169 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Playtika Holding.
Find out more about how you can short Playtika Holding stock.
We're not expecting Playtika Holding to pay a dividend over the next 12 months.
Playtika Holding Corp. develops mobile games in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company owns a portfolio of casual and casino-themed games. It distributes its games to the end customer through various web and mobile platforms, such as Apple, Facebook, Google, and other web and mobile platforms and its own proprietary platforms. The company was founded in 2010 and is headquartered in Herzliya Pituarch, Israel. Playtika Holding Corp. operates as a subsidiary of Playtika Holding Uk Ii Limited.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.